Skip to content

The comparison of nalbuphine and sufentanil in total intravenous anesthesia in the adult patients

The comparison of nalbuphine and sufentanil in total intravenous anesthesia in the adult patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047296
Enrollment
Unknown
Registered
2021-06-11
Start date
2021-06-10
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodynamic alteration in response to anesthesia induction

Interventions

Control group:sufentanil 0.3µg/kg
Experimental group:nalbuphine 0.3mg/kg

Sponsors

The department of anesthesilogy, Zichang People's Hospital, Shaanxi, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective surgery under general anesthesia; 2. Aged 18 to 64 years; 3. BMI 18-29.5; 4. There is no restriction on gender; 5. ASA classification i-iii level; 6. The operation method is a small and medium-sized operation completed within 2 hours.

Exclusion criteria

Exclusion criteria: 1. Patients with diabetes, Cushing syndrome, pituitary tumor, adrenal tumor and other diseases; 2. Patients who use hormone drugs for a long time; 3. Asthma patients; 4. Within 2 weeks of taking monoamine oxidase inhibitor; 5. Patients with severe neurological or mental illness; 6. Chronic pain and long-term use of analgesics or psychotropic drugs (opioid analgesics, non-steroidal anti-inflammatory drugs, sedatives, antidepressants) history; 7. The heart, lung, liver, and kidney functions are severely abnormal; 8. Patients with severe hypertension or hypotension; 9. Patients with bradycardia or tachycardia; 10. Use sedatives, antiemetics and antipruritic drugs 24 hours before surgery; 11. Patients who are allergic to soybeans, milk, and drugs used during surgery; 12. Other factors that may interfere with the results of the experiment.

Design outcomes

Primary

MeasureTime frame
Heart rate;Systolic blood pressure ;Diastolic blood pressure;Mean arterial pressure ;

Secondary

MeasureTime frame
The alterations in HR after intubation;The consumption of opioid drug;The hemodynamic change >=20%;The times and doses of vaszoactive agents;extubation time;

Countries

China

Contacts

Public ContactXu Jun

The department of anesthesilogy, Zichang People's Hospital

52350787@qq.com+86 13991777731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026